Virtus ETF Advisers LLC Avrobio, Inc. Transaction History

Virtus ETF Advisers LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $76,741 - $134,576	-22,244 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.53 - $9.28 $6,381 - $10,709	-1,154 Reduced 4.93%	22,244 $124,000
Q2 2021 Aug 10, 2021	BUY	$7.84 - $12.6 $9,047 - $14,540	1,154 Added 5.19%	23,398 $208,000
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $4,121 - $7,546	391 Added 1.79%	22,244 $282,000
Q4 2020 Feb 12, 2021	BUY	$12.79 - $17.1 $99,736 - $133,345	7,798 Added 55.48%	21,853 $305,000
Q3 2020 Nov 13, 2020	SELL	$12.99 - $19.41 $24,681 - $36,879	-1,900 Reduced 11.91%	14,055 $183,000
Q2 2020 Aug 05, 2020	SELL	$12.19 - $22.96 $5,839 - $10,997	-479 Reduced 2.91%	15,955 $278,000
Q1 2020 May 14, 2020	SELL	$10.08 - $27.21 $24,141 - $65,167	-2,395 Reduced 12.72%	16,434 $256,000
Q4 2019 Feb 13, 2020	BUY	$13.05 - $21.88 $2,257 - $3,785	173 Added 0.93%	18,829 $379,000
Q3 2019 Nov 12, 2019	SELL	$14.12 - $23.44 $14,670 - $24,354	-1,039 Reduced 5.28%	18,656 $263,000
Q2 2019 Aug 13, 2019	BUY	$13.21 - $27.29 $116,842 - $241,380	8,845 Added 81.52%	19,695 $320,000
Q1 2019 May 14, 2019	SELL	$12.46 - $22.05 $17,780 - $31,465	-1,427 Reduced 11.62%	10,850 $239,000
Q4 2018 Feb 05, 2019	BUY	$15.43 - $32.7 $189,434 - $401,457	12,277 New	12,277 $204,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.